Skip to content
10-K/A

Annual Report

RADIENT PHARMACEUTICALS CORP

0001144204-12-038691

← back to feed
Filed
Jul 9, 2012 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2011 · Jun 15, 2012 1.35B sh
Capex FY 2011 · Dec 31, 2011 $30.46K
Capex FY 2011 · Dec 31, 2010 $27.99K
Operating Cash Flow FY 2011 · Dec 31, 2011 −$5.65M
Operating Cash Flow FY 2011 · Dec 31, 2010 −$7.11M
Stockholders Equity FY 2011 · Dec 31, 2011 −$49.69M
Stockholders Equity FY 2011 · Dec 31, 2010 −$52.89M
Stockholders Equity FY 2011 · Dec 31, 2009 $20.69M
Current Liabilities FY 2011 · Dec 31, 2011 $50.87M
Current Liabilities FY 2011 · Dec 31, 2010 $53.75M
Current Assets FY 2011 · Dec 31, 2011 $1.11M
Current Assets FY 2011 · Dec 31, 2010 $775.63K
Total Assets FY 2011 · Dec 31, 2011 $1.18M
Total Assets FY 2011 · Dec 31, 2010 $856.96K
Sga Expense FY 2011 · Dec 31, 2011 $10.12M
Sga Expense FY 2011 · Dec 31, 2010 $9.88M
Rd Expense FY 2011 · Dec 31, 2011 $115.48K
Rd Expense FY 2011 · Dec 31, 2010 $673.92K
Net Income FY 2011 · Dec 31, 2011 −$86.19M
Net Income FY 2011 · Dec 31, 2010 −$85.71M
Operating Income FY 2011 · Dec 31, 2011 −$9.97M
Operating Income FY 2011 · Dec 31, 2010 −$14.1M
Gross Profit FY 2011 · Dec 31, 2011 $261.78K
Gross Profit FY 2011 · Dec 31, 2010 $185.34K
Cost Of Revenue FY 2011 · Dec 31, 2011 $51.78K
Cost Of Revenue FY 2011 · Dec 31, 2010 $46.33K